Difference between revisions of "Melanotic Xp11 translocation renal cancer"

From Libre Pathology
Jump to navigation Jump to search
(+images)
(more)
Line 1: Line 1:
{{ Infobox diagnosis
| Name      = {{PAGENAME}}
| Image      =
| Width      =
| Caption    =
| Synonyms  =
| Micro      =
| Subtypes  =
| LMDDx      =
| Stains    =
| IHC        =
| EM        =
| Molecular  = Xp11 translocation
| IF        =
| Gross      =
| Grossing  = [[partial nephrectomy grossing]], [[Total nephrectomy for tumour grossing]]
| Staging    =
| Site      = [[kidney]] - see ''[[kidney tumours]]''
| Assdx      =
| Syndromes  =
| Clinicalhx =
| Signs      =
| Symptoms  =
| Prevalence = case reports
| Bloodwork  =
| Rads      =
| Endoscopy  =
| Prognosis  = unknown
| Other      =
| ClinDDx    = other renal tumours
| Tx        = excision
}}
'''Melanotic Xp11 translocation renal cancer''' is a very rare [[kidney tumour]] that is evolving as an entity.<ref name=pmid26274027>{{Cite journal  | last1 = Rao | first1 = Q. | last2 = Shen | first2 = Q. | last3 = Xia | first3 = QY. | last4 = Wang | first4 = ZY. | last5 = Liu | first5 = B. | last6 = Shi | first6 = SS. | last7 = Shi | first7 = QL. | last8 = Yin | first8 = HL. | last9 = Wu | first9 = B. | title = PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity. | journal = Am J Surg Pathol | volume = 39 | issue = 9 | pages = 1181-96 | month = Sep | year = 2015 | doi = 10.1097/PAS.0000000000000502 | PMID = 26274027 }}</ref>
'''Melanotic Xp11 translocation renal cancer''' is a very rare [[kidney tumour]] that is evolving as an entity.<ref name=pmid26274027>{{Cite journal  | last1 = Rao | first1 = Q. | last2 = Shen | first2 = Q. | last3 = Xia | first3 = QY. | last4 = Wang | first4 = ZY. | last5 = Liu | first5 = B. | last6 = Shi | first6 = SS. | last7 = Shi | first7 = QL. | last8 = Yin | first8 = HL. | last9 = Wu | first9 = B. | title = PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity. | journal = Am J Surg Pathol | volume = 39 | issue = 9 | pages = 1181-96 | month = Sep | year = 2015 | doi = 10.1097/PAS.0000000000000502 | PMID = 26274027 }}</ref>


Revision as of 05:13, 2 January 2018

Melanotic Xp11 translocation renal cancer
Diagnosis in short
Molecular Xp11 translocation
Grossing notes partial nephrectomy grossing, Total nephrectomy for tumour grossing
Site kidney - see kidney tumours
Prevalence case reports
Prognosis unknown
Clin. DDx other renal tumours
Treatment excision

Melanotic Xp11 translocation renal cancer is a very rare kidney tumour that is evolving as an entity.[1]

General

  • Evolving entity.[2][1]
  • Very rare.

Microscopic

Features:

DDx:

Images

  • MXTRC - low mag.

  • MXTRC - intermed. mag.

  • MXTRC - high mag.

  • MXTRC - very high mag.

  • MXTRC - low mag.

  • MXTRC - intermed. mag.

  • MXTRC - high mag.

  • MXTRC - high mag.

IHC

  • TFE3 +ve.
  • Keratin -ve.

Molecular

  • TFE3 rearrangement.

See also

References

  1. ↑ 1.0 1.1 Rao, Q.; Shen, Q.; Xia, QY.; Wang, ZY.; Liu, B.; Shi, SS.; Shi, QL.; Yin, HL. et al. (Sep 2015). "PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.". Am J Surg Pathol 39 (9): 1181-96. doi:10.1097/PAS.0000000000000502. PMID 26274027.
  2. ↑ Argani, P.; Aulmann, S.; Karanjawala, Z.; Fraser, RB.; Ladanyi, M.; Rodriguez, MM. (Apr 2009). "Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma.". Am J Surg Pathol 33 (4): 609-19. doi:10.1097/PAS.0b013e31818fbdff. PMID 19065101.
Retrieved from "https://librepathology.org/w/index.php?title=Melanotic_Xp11_translocation_renal_cancer&oldid=48496"